Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Valeant Pharmaceuticals Intl (NY: VRX)
N/A USD  UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close -
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 348,708,567
Dividend Yield N/A
Performance
Top News
More News
Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter 2019 financial results on Tuesday, Aug. 6, 2019. Bausch Health will host a conference call and live web... Read More
from PR Newswire
Global Aesthetic Laser Medical Devices Pipeline Assessment 2019
The "Aesthetic Laser - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive information on the pipeline products with... Read More
from GlobeNewswire News Releases
More News
Read More
Bausch + Lomb Receives 510(K) Clearance From FDA For Bausch + Lomb Ultra® Multifocal For Astigmatism Contact Lenses
from PR Newswire
Bausch Health Launches ALTRENO™ (tretinoin) Lotion, 0.05% In The United States
from PR Newswire
Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO™ (tretinoin) Lotion, 0.05% In The Journal Of Drugs In Dermatology
from PR Newswire
Aesthetic Laser Medical Devices Pipeline Assessment 2019 by Stage of Development, Territory, Regulatory Path, Estimated Approval Date & Ongoing Clinical Trials - ResearchAndMarkets.com
from Business Wire News Releases
International Ophthalmology and Optometry Devices Market Booming With New Growth Opportunities
from PR Newswire
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
from PR Newswire
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine)
from PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX
from ACCESSWIRE
6 Valuable Pipeline Drugs With Upcoming Catalysts
category Market News , BMY , XBI , and 17 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.